Brainstorm announces scientific presentation of nurown® exosome preclinical ards data at isct 2021 new orleans virtual meeting

New york, may 25, 2021 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of cellular therapies for neurodegenerative diseases, announced the presentation today of a poster titled, "molecular mechanisms underlying msc-ntf (nurown®) exosome benefits in a mouse lps-induced ards model" at the isct 2021 new orleans virtual meeting, being held from may 25-28, 2021.  the poster will be presented during virtual poster hall session 2: may 25, 20:00-21:30 edt.
BCLI Ratings Summary
BCLI Quant Ranking